# ATORVASTATIN CALCIUM
> **ANDA217634** · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2023-12-21
## Drug
- **FDA Application Number:** ANDA217634
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ATORVASTATIN CALCIUM
- **Generic name:** Atorvastatin Calcium
- **Active ingredients:** ATORVASTATIN CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** STRIDES PHARMA
- **First approval:** 2023-12-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217634)
---
*MORVS · CC0 1.0*